KATHMANDU, Feb 13: Pfizer's new bivalent vaccines have arrived in Nepal. As many as 345,000 doses of the vaccine have entered Nepal. Surendra Chaurasiya, head of the Supply Branch of the Department of Health Services, said that the vaccines were delivered at 9AM on Monday.

KATHMANDU, June 23: Pfizer vaccine against COVID-19 was administered to children under the age of 5-12 years at Shanti Nikunja School, Basantapur on Thursday.

LALITPUR, Feb 1: The Lalitpur Metropolitan City (LMC) is administering the second dose of Pfizer COVID-19 vaccine starting Thursday.

Jan 15: Pfizer Inc (PFE.N) said on Wednesday booster doses of its COVID-19 vaccine can be administered along with its pneumonia vaccine and produced strong safety and immune responses in people aged 65 and above in a late-stage study.

Dec 17: Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday.

Dec 9: BioNTech and Pfizer (PFE.N) said on Wednesday a three-shot course of their COVID-19 vaccine was able to neutralise the new Omicron variant in a laboratory test, an early signal that booster shots could be key to protection against infection from the newly identified variant.

Dec 8: The Omicron variant can partially evade protection from two doses of Pfizer (PFE.N) and partner BioNTech's COVID-19 vaccine, the research head of a laboratory at the Africa Health Research Institute in South Africa said on Tuesday.

Dec 7: A major British study into mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of AstraZeneca or Pfizer-BioNTech shots followed by Moderna nine weeks later, according to the results on Monday.

WASHINGTON, Nov 17: Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.

U.S., Nov 10: Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings.

AP, Oct 23: Federal health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning vaccinations in youngsters.

KATHMANDU, Oct 3: State Minister for Health and Population, Umesh Shrestha has said that children below the age of 18 will be administered vaccines against COVID-19 right after Dashain.

WASHINGTON, Sept 29: Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November.

August 10: The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19.

NEW YORK, July 8:  Pfizer Inc (PFE.N) plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, the drugmaker's top scientist said on Thursday, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant.

July 9: Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.

June 25: The U.S. drug regulator on Friday added a warning to the literature that accompanies Pfizer Inc (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O) COVID vaccine shots to indicate the rare risk of heart inflammation after its use.

USA, April 1: Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they head back to school in the fall.

WASHINGTON DC, Dec 13: The first trucks carrying a COVID-19 vaccine for widespread use in the United States were set to pull out of a Michigan manufacturing plant Sunday, with the shots that are critical to stopping the nation’s coronavirus outbreak destined to reach states a day later.

LONDON, Dec 12: The U.S. Food and Drug Administration said it authorized the use of Pfizer Inc’s COVID-19 vaccine on Friday, with the first inoculations expected within days, marking a turning point in the United States where the pandemic has killed more than 295,000 people.

NEW YORK, Nov 20: Pfizer Inc said it will apply to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus.

NEW YORK, Nov 19: Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side effects, the drugmakers said on Wednesday.

A meeting of high-ranking government officials has been scheduled for today to discuss procuring COVID-19 vaccines

NEW YORK, Nov 9: Pfizer Inc said on Monday its experimental COVID-19 vaccine was more than 90% effective, a major victory in the fight against a pandemic that has killed more than a million people, battered the world’s economy and upended daily life.

BRUSSELS, Oct 19: Pfizer, one of the leading companies in COVID-19 vaccine production, has manufactured hundreds of doses of drugs in Belgium, reports 9new.com.